HKG: 0013

Company Drug

Inmagene and HutchMed Dose First Patient in IMG-007 Global Phase I Study

Fineline Cube Jul 6, 2022

China-based Inmagene Biopharmaceuticals and HutchMed (NASDAQ: HCM, HKG: 0013) announced the completion of first patient...

Company Deals

Johnson & Johnson Completes Acquisition of Intra-Cellular Therapies

Company Deals Medical Device

Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development

Company

Boehringer Ingelheim Reports 6.1% Sales Growth in 2024, Bolstered by Key Pharmaceuticals

Company Deals

GE Healthcare Partners with Probo Medical to Distribute Ultrasound Devices